Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Campistol

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Kidney International|October 10, 2002
Uremic myopathyJosep M Campistol
Nature Clinical Practice. Nephrology|August 26, 2006
Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?Josep M Campistol
Transplantation Proceedings|November 1, 2015
PrefaceJosep M Campistol
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 6, 2010
[Minimizing the risk of cancer in transplant patients]Josep M Campistol
Transplantation|April 23, 2009
Minimizing the risk of posttransplant malignancyJosep M Campistol
Transplantation Proceedings|January 30, 2016
Gold Medal of the Catalan Transplantation Society to Dr. Juan Carlos Izpisúa BelmonteJosep M Campistol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2005
Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risksFritz Diekmann, Josep M Campistol
Transplantation Research|June 14, 2016
Practical considerations for the use of mTOR inhibitorsFritz Diekmann, Josep M Campistol
Drugs|May 25, 2007
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic reviewAlex Gutierrez-Dalmau, Josep M Campistol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitorsJosep M Campistol, Francesco P Schena
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Kidney International|October 10, 2002
Uremic myopathyJosep M Campistol
Nature Clinical Practice. Nephrology|August 26, 2006
Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?Josep M Campistol
Transplantation Proceedings|November 1, 2015
PrefaceJosep M Campistol
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 6, 2010
[Minimizing the risk of cancer in transplant patients]Josep M Campistol
Transplantation|April 23, 2009
Minimizing the risk of posttransplant malignancyJosep M Campistol
Transplantation Proceedings|January 30, 2016
Gold Medal of the Catalan Transplantation Society to Dr. Juan Carlos Izpisúa BelmonteJosep M Campistol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 20, 2005
Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risksFritz Diekmann, Josep M Campistol
Transplantation Research|June 14, 2016
Practical considerations for the use of mTOR inhibitorsFritz Diekmann, Josep M Campistol
Drugs|May 25, 2007
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic reviewAlex Gutierrez-Dalmau, Josep M Campistol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 26, 2007
Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitorsJosep M Campistol, Francesco P Schena
Pageof 21